Clarus Therapeutics Holdings, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
MRKMerck & Co., Inc. 1.92%81.020.7%$1593.19m
JNJJohnson & Johnson 0.34%164.420.7%$1033.68m
PFEPfizer Inc. 1.87%42.880.9%$941.46m
ABBVAbbVie, Inc. 1.05%108.581.9%$680.65m
BMYBristol-Myers Squibb Co. 1.18%58.271.0%$661.00m
LLYEli Lilly & Co. 0.61%243.791.1%$610.79m
AZNAstraZeneca Plc 0.96%60.751.0%$367.57m
NVSNovartis AG 1.94%84.760.2%$177.42m
GSKGlaxoSmithKline Plc 0.86%39.510.2%$162.17m
RGENRepligen Corp. 2.65%269.606.8%$118.68m
AVIRAtea Pharmaceuticals, Inc. -3.62%13.320.3%$117.46m
VTRSViatris, Inc. 3.17%14.000.0%$92.87m
NVONovo Nordisk A/S -0.08%104.570.1%$91.62m
EDSAEdesa Biotech, Inc. -0.73%8.160.0%$73.55m
SNYSanofi 2.76%49.390.2%$65.20m

Company Profile

Clarus Therapeutics Holdings, Inc. is a pharmaceutical company with expertise in developing androgen and metabolic therapies for men and women, including potential therapies for orphan indications. the company's first commercial product is JATENZO. It is headquartered in Northbrook, IL.